$KN

Knowles Corp (KN): Results of Operations and Financial Condition

Knowles Corp (KN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q22026.htm EX-99.1 Document Exhibit 99.1 Financial Contact: Sarah Cook Knowles Investor Relations Email: investorrelations@knowles.com Knowles Reports Q2 2026 Financial Results and Provides Outlook for Q3 2026 Q2 Revenues Increased 14% on a Year over Year Basi

Original reporting
Published Jul 23, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$KN
Bullish
medium confidence
Mentioned
$KN
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$KNBullishMed
01

Why it matters

The key tradable elements are the Q2 print (revenues, GAAP and non-GAAP EPS, operating cash flow) and the explicit Q3 guidance ranges, plus management’s 2026 growth expectations (10-12% revenue growth and adjusted EBITDA growth >20%).

02

Market read

This filing updates the company’s near-term earnings expectations via Q3 guidance and reinforces a 2026 growth framework tied to bookings and backlog.

03

What to watch

Cash from operations was $28.2 million in Q2 versus $36.4 million in Q2 2025, so traders may scrutinize working-capital swings and the sustainability of operating cash conversion into future quarters.

Relevance 7/10Novelty 8/10Timing: after-hours, ahead of Q3 2026 results

Background

Knowles filed an SEC 8-K (Item 2.02) with Q2 2026 results for continuing operations and provided forward guidance for the quarter ending September 30, 2026.

Company-level read

Ticker impact

$KNBullishMedium confidence
Context

Knowles reported Q2 2026 results and issued Q3 2026 guidance for revenues $167 to $177 million and EPS $0.34 to $0.38 (non-GAAP).

Expected impact

Likely near-term positive bias if investors view the Q3 range and 2026 outlook as credible versus expectations, with upside/downside sensitivity to revenue and non-GAAP EPS midpoint.

Evidence & confidence

This is a primary 8-K earnings release with explicit Q3 guidance ranges and a stated 2026 revenue growth target (10-12%) and adjusted EBITDA growth (>20%).

Market effects

Signals demand and margin durability in specialty electronic components (precision devices, medtech, defense, industrial, electrification) that can influence sentiment across the component supply chain.

Limited, primarily company-specific given the filing is not a macro or regional policy event.

Moderate, as defense and medtech end markets can affect broader electronics component demand expectations, but the disclosure is company-specific.

Counterpoint

The outlook is growth-oriented, but investors may focus on whether bookings/backlog translate into revenue timing, and whether non-GAAP strength masks GAAP or cash flow volatility.

Key entities

  • Knowles Corp

    Specialty electronic components manufacturer reporting Q2 2026 results and issuing Q3 2026 guidance.

  • Jeffrey Niew

    President and CEO quoted on performance, bookings/backlog, and 2026/2027 outlook.

Related articles

$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

$GPRKMed

Geopark Q2 Earnings Call Highlights

Geopark (NYSE:GPRK) reported Q2 earnings call updates. It plans $40m to $50m of Vaca Muerta investment in 2H 2026 after $55m in 1H, with 70% to 80% in Q3. Full-year lifting costs are guided at $17 to $19/bbl. Cash rose to $316m, net leverage fell to 1.2x EBITDA, and a $0.023/share quarterly dividend was declared.

$GRDNMed

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) reported Q2 net income of $22.1M vs $8.8M a year earlier, including an $8.5M payer-dispute settlement recorded as other income. The company expects H2 revenue to fall low-single digits YoY due to IRA pricing reductions, with adjusted EBITDA margin stable in Q3 and seasonally higher in Q4. It also appointed Morris as COO and named a new CFO.

$GPNMed

Global Payments Q2 Earnings Call Highlights

Global Payments (NYSE:GPN) reported Q2 results and discussed its Worldpay integration and Genius point-of-sale rollout. Management guided for about 4.5% revenue growth in 2H, margins near 43%, and cited drivers including sales-force ramp and enterprise go-lives. Q2 adjusted net revenue by segment: SMB $1.51B, Enterprise $838M, Platforms $628M. Adjusted free cash flow was $687M; net leverage just below 3.5x.

$CXWMed

Private prisons announce $1.4 billion in revenue as immigration detentions climb

CoreCivic and GEO Group reported combined $1.4 billion in quarterly revenue for April-June as U.S. immigration detention nears record levels. CoreCivic said revenue rose 27% to $684.9 million, including a $1.6 billion DHS facility sale not yet reflected. GEO Group reported $732.1 million revenue, up 15%, with growth in ICE ankle monitoring and related services.